MentionFox
Home › Layoffs › Foghorn Therapeutics Inc.
SEC filings · Form 8-K, Item 2.05

Foghorn Therapeutics Inc. layoffs and restructuring

Every exit or restructuring plan Foghorn Therapeutics Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

Owed money by them or selling to them? See the free Snapshot of Foghorn Therapeutics Inc.

Watch Foghorn Therapeutics Inc.

Free to see. No signup.

SEC filings1
Latest, employees65
Latest filing2026-10-01

Foghorn Therapeutics Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

SEC filings: exit or restructuring (Item 2.05)

Foghorn Therapeutics Inc. (CIK 1822462) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2026-10-01

Employees affected

Following the changes, the Company expects to have approximately 65 full-time employees.

Share of workforce

In connection with this decision, the Company announced a reduction in its workforce by approximately 40% of its current workforce.

Expected charges

The Company estimates that, in connection with these changes, it will incur aggregate charges of approximately $2.3 million, all of which are anticipated to result in future cash expenditures, primarily for one-time employee severance and benefit costs that are expected to be incurred in the fourth quarter of 2026.

Timing

The Company expects to substantially complete the reduction in its workforce in the fourth quarter of 2026.

Also on the record for Foghorn Therapeutics Inc.

DateRecordFigureOur pageSource
October 5, 2026Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL14.3% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL9.99% of the class5%+ stakesSource
May 14, 2026Stake report, Schedule 13G/A, by Deerfield Mgmt, L.P.8.64% of the class5%+ stakesSource
May 6, 2026Stake report, Schedule 13G/A, by FMR LLC11.6% of the class5%+ stakesSource
January 13, 2026Stake report, Schedule 13D/A, by Flagship Ventures Fund V, L.P.27.2% of the class5%+ stakesSource

What do you want to do with Foghorn Therapeutics Inc.?

Want the whole picture on Foghorn Therapeutics Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Foghorn Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Foghorn Therapeutics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    6 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

Tools for this story

Each opens in a new tab, filled in for Foghorn Therapeutics Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/foghorn-therapeutics
Last updated 2026-10-18
Foghorn Therapeutics Inc. layoffs and restructuring: 1 SEC filing, latest about 65 employees (2026-10-01). MentionFox, 2026-10-18. https://mentionfox.com/layoffs/foghorn-therapeutics